Cargando…
Safety of Repeated-Dose Intratympanic Injections with AM-101 in Acute Inner Ear Tinnitus
OBJECTIVE: To evaluate the safety and tolerability of repeated intratympanic administration of the gel-formulated NMDA receptor antagonist AM-101 in acute patients with inner ear tinnitus. STUDY DESIGN: Prospective, double-blind, randomized, placebo-controlled study. SETTING: Sixty-nine secondary an...
Autores principales: | Staecker, Hinrich, Morelock, Michael, Kramer, Timothy, Chrbolka, Pavel, Ahn, Joong Ho, Meyer, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673013/ https://www.ncbi.nlm.nih.gov/pubmed/28608739 http://dx.doi.org/10.1177/0194599817711378 |
Ejemplares similares
-
Intratympanic Lipopolysaccharide Elevates Systemic Fluorescent Gentamicin Uptake in the Cochlea
por: Chai, Yongchuan, et al.
Publicado: (2021) -
Inner ear delivery: Challenges and opportunities
por: Szeto, Betsy, et al.
Publicado: (2019) -
Quality of life after intratympanic steroid injection for Ménière's disease
por: Schenck, Annejet A., et al.
Publicado: (2022) -
Prevalence of Tinnitus in an Aging Population and Its Relation to Age and Hearing Loss
por: Oosterloo, Berthe C., et al.
Publicado: (2020) -
Oral and intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss
por: Hara, Jared H., et al.
Publicado: (2018)